
Hélène Bénédetti
126
Documents
Publications
58
23
19
18
18
17
16
16
15
13
13
12
12
12
11
10
8
8
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
Publications
The Tol/PAL and TonB systems : two envelope-spanning protein complexes involved in colicin import in E. coli.Molecular Dynamics of Biomembranes, Springer Berlin Heidelberg, pp.59-69, 1996
Chapitre d'ouvrage
hal-02130680
v1
|
|
Colicin transport, channel formation and inhibitionHandbook of Biological Physics, pp.665-691, 1996
Chapitre d'ouvrage
hal-02130677
v1
|
|
Insertion of Proteins into Membranes A SurveyMembrane biogenesis, pp.21-69, 1994, Subcellular Biochemistry, 978-1-4613-6018-6
Chapitre d'ouvrage
hal-02130265
v1
|
|
Import of Colicins into Escherichia ColiDynamics of Membrane Assembly, 63, Springer Berlin Heidelberg, pp.315-332, 1992
Chapitre d'ouvrage
hal-02130670
v1
|
|
Study of the Import Mechanisms of Colicins Through Protein Engineering and K+ Efflux KineticsBacteriocins, Microcins and Lantibiotics, Springer Berlin Heidelberg, pp.215-223, 1992
Chapitre d'ouvrage
hal-02130674
v1
|
|
In Vivo Properties of Colicin A: Channel Activity and TranslocationBacteriocins, Microcins and Lantibiotics, Springer Berlin Heidelberg, pp.119-125, 1992
Chapitre d'ouvrage
hal-02130671
v1
|
|
Molecular Mechanism of Action of Pore-Forming Colicins and of their Immunity ProteinsMembrane Proteins: Structures, Interactions and Models, pp.413-425, 1992
Chapitre d'ouvrage
hal-02130675
v1
|
4-(7H-Pyrrolo[2,3-D]pyrimidin-4-yl)-3,6-dihydropyridine-(2H)-carboxamide derivatives as Limk and/or Rock kinases inhibitors for use in the treatment of cancerFrance, Patent n° : WO2021239727 A1. AMV. 2021
Brevet
hal-03555349
v1
|
|
TRISUBSTITUTED PYRIDO[2,3-D]PYRIMIDINES, METHODS FOR PREPARING SAME AND THERAPEUTIC USES THEREOFFrance, Patent n° : WO2014027081. 2014
Brevet
hal-02131560
v1
|
|
Tools for the identification od LINGO-1, LINGO-2, LINGO-3 and LINGO-4, ligands, and uses thereofFrance, Patent n° : WO2011121257. BCT. 2011
Brevet
hal-02130935
v1
|
|
Noncanonical structural requirements of neurofibromin SUMOylation reveal a folding-deficiency of several pathogenic mutants2022
Pré-publication, Document de travail
hal-03668582
v1
|
Chargement...
Chargement...